Riskpilot← Back to searchSign inGet full accessCureum AB
ABActiveOrg 5566818661Fabriksgatan 22Medical specialists activities · NACE 8622Est. 200557 employees
Revenue 2024
SEK 62M
-11% vs 2023
EBITDA margin
-3.5%
-2084% vs 2023
Equity ratio
10.8%
Financial strength
Net profit 2024
SEK -91K
57 employees
| Revenue | SEK 62M | -11% |
| EBITDA | SEK -2,2M | -2084% |
| Net profit | SEK -91K | — |
| Total assets | SEK 9,6M | +6% |
| Equity | SEK 1M | -8% |
| Employees | 57 | — |
Legal name
Cureum AB
Org number
5566818661
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
14 juni 2005
Share capital
SEK 100 000
Employees
57 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva utredning, behandling och utbildning samt forskning inom sjukvård, bolaget skall även bedriva socialt arbete, konsulentstödd familjevård, upplåta - hem för vård och, eller boende - HVB, genomföra utbildning, handledning och forskning inom det samhällsvetenskapliga området samt därmed förenlig verksamhet.
Address
Fabriksgatan 22
Phone
+46196033591
Email
ekonomi.iof@humana.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 21 981 | 17 907 | 22 852 | 25 188 | 35 691 | 69 793 | 62 025 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −3 337 | −6 895 | −6 941 | 247 | −5 017 | −2 797 | −1 370 | −578 | 110 | −2 182 |
| Depreciation & amort. | −0 | −0 | −3 | −14 | −20 | −5 | −0 | −0 | −0 | −0 |
| EBIT | −3 337 | −6 895 | −6 944 | 233 | −5 037 | −2 802 | −1 370 | −578 | 110 | −2 182 |
| Net financials | 3 | 3 | −1 | −2 | −1 | — | — | −1 | 1 | — |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −91 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −91 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 270 | 8 758 | 9 646 | 7 298 | 7 704 | 6 860 | 6 474 | 6 914 | 9 078 | 9 631 |
| Equity | 1 129 | 1 129 | 1 129 | 1 129 | 1 129 | 1 129 | 1 129 | 1 129 | 1 129 | 1 038 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 141 | 7 629 | 8 517 | 6 169 | 6 575 | 5 731 | 5 345 | 5 785 | 7 949 | 8 593 |
| Total debt | 1 141 | 7 629 | 8 517 | 6 169 | 6 575 | 5 731 | 5 345 | 5 785 | 7 949 | 8 593 |
EBITDA margin
-3.5%
This company
15.8%
Market median
-122% vs market
20152024
Equity ratio
10.8%
This company
38.2%
Market median
-72% vs market
20152024
Return on equity
-8.8%
This company
18.4%
Market median
-148% vs market
20152024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20152024
Asset turnover
6.44×
This company
1.12×
Market median
+475% vs market
20152024
Debt / equity
8.28×
This company
0.62×
Market median
-1235% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NC Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
JF Chief Auditor | Chief Auditor | 2025 | — | — |
TC Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
HE Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Humana Bu Holding AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Humana Holding AB
Cureum AB Board members of Cureum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Noora Chandrika Jayasekara | Chief Executive Officer | 0 companies |
| Johan Fredrik Westin | Chief Auditor | 0 companies |
| Titti Christina Lilja | Chief Executive Officer | 0 companies |
| Helena Eva Marie Nilsson | Chief Auditor | 0 companies |
| Rasmus Olof Nerman | Chairman | 0 companies |
| Hans Anders Michael Dahlgren | Board of Directors | 0 companies |
| Ulf Sören Bonnevier | Board of Directors | 0 companies |
| Nathalie Karly Boulas Nilsson | Chairman | 0 companies |
| Johanna Maria Rastad | Chairman | 0 companies |